IL5 and neoplasm: Previous studies suggest that Th2 can exhibit both anti-tumor activity (via cytokine IL-5 mediated recruitment of eosinophils), and pro-tumor activity (via cytokine e.g., IL-4 mediated suppression of pro-tumor Th1 cells)31,32.